Key facts
- This page summarizes Ruby Sharma's Form 4 filing for Aspira Women's Health Inc. (AWHL).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 29 Aug 2022, 21:39.
Ruby Sharma - 25 Aug 2022 Form 4 Insider Report for Aspira Women's Health Inc. (AWHL)
- Reporting relationship
- Director
- Issuer ticker
- AWHL
- Reported as of
- 25 Aug 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 29 Aug 2022, 21:39:40 UTC
- Prior SEC filing
- 24 Aug 2022
- Next SEC filing
- 13 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ruby Sharma
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ruby Sharma filed Form 4 for Aspira Women's Health Inc. (AWHL) on 29 Aug 2022.
Change
- Previous filing in this sequence was filed on 24 Aug 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AWH
transaction
Common Stock
Purchase
- Transaction value
- Shares
- +13,332
- Change %
- +12%
- Price
- Shares after
- 127,550
- Date
- 25 Aug 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AWH
transaction
Derivative
Warrant (right to buy)
Purchase
- Transaction value
- Shares
- +13,332
- Change %
- Price
- Shares after
- 13,332
- Date
- 25 Aug 2022
- Ownership
- Direct
- Underlying class
- Common stock, par value $0.001
- Underlying amount
- 13,332
- Exercise price
- $0.8800
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Each share of common stock was purchased together with one warrant to purchase one share of common stock (each share and related warrant, a "unit"), at a price of $0.75 per unit.